Status:
UNKNOWN
Real-Life Use of Anti-fibrotic Drugs in Patients With Idiopathic Pulmonary Fibrosis in Sweden
Lead Sponsor:
Karolinska University Hospital
Conditions:
Idiopathic Pulmonary Fibrosis
Eligibility:
All Genders
Brief Summary
The objective of the current research project is, by using high quality Swedish registry data, to evaluate use, tolerance and effect of anti-fibrotic drugs in IPF-patients. Secondary study objectives ...
Eligibility Criteria
Inclusion
- All subjects included in the Swedish IPF-registry
Exclusion
- None
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04019080
Start Date
January 1 2019
End Date
December 1 2021
Last Update
July 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska University Hospital
Stockholm, Sweden